Skip to content

Cash ratio at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
+0.3×
Labcorp Holdings logo
Labcorp HoldingsLH
0.4×+0.2×
Quest Diagnostics logo
Quest DiagnosticsDGX
0.2×0.0×
Natera, Inc. logo
Natera, Inc.NTRA
1.9×-0.7×
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
9.4×
Revvity logo
RevvityRVTY
0.7×-1.1×

Other financials

Income statement

See full
Revenue$14.0K-63.2%
Operating income-$9.4M-1.2%
Net income-$8.4M-2.6%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$4.2M-20.2%
Total debt$2.5M+286%
Total equity$67.6M-28.7%
Total assets$93.5M-20.8%

Cash flow

See full
Operating cash flow-$8.8M-16.2%
CapEx$8.0K+167%
Free cash flow-$8.8M-16.2%

Valuation

See full
Market cap$71.27M+5.0%
Enterprise value$69.6M+9.6%
P/S1,250.3×+622×

Profitability

See full
Operating margin-64,235.1%-8,092,342pp
Net margin-56,386%+1,586,573pp
FCF margin-48,377.2%-673,104pp

Returns & leverage

See full
Return on equity-39.6%-1.6pp
Debt / equity0.0×
Current ratio2.1×+0.1×

Where this comes from

Calculated from Sera Prognostics’s reported figures.

Based on the most recent quarter.

The official record: Sera Prognostics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sera Prognostics's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sera Prognostics's cash ratio?
Sera Prognostics (SERA) reported cash ratio of 0.2× in Q1 2026.
How has Sera Prognostics's cash ratio changed year-over-year?
Sera Prognostics's cash ratio decreased by 20.2% year-over-year, from 0.2× to 0.2×.
What is the long-term trend for Sera Prognostics's cash ratio?
Over 5 years (2020 to 2025), Sera Prognostics's cash ratio has grown at a -33.0% compound annual growth rate (CAGR), from 1.2× to 0.2×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.